Company Filing History:
1 out of 1,745 
1 out of 33 
1 out of 71 Years Active: 2020
Title: Inna Menkova-Garnier: Innovator in HIV Research
Introduction
Inna Menkova-Garnier is a notable inventor based in Créteil, France. She has made significant contributions to the field of medical research, particularly in the area of HIV treatment. Her innovative work has led to the development of a patent that addresses critical health challenges faced by individuals infected with the human immunodeficiency virus.
Latest Patents
Inna Menkova-Garnier holds a patent for "P2X7 receptor antagonists for restoring T-cell lymphopoiesis in subjects infected with human immunodeficiency virus (HIV)." This invention relates to a pharmaceutical composition designed to restore T-cell lymphopoiesis in HIV-infected subjects. The method involves administering a therapeutically effective amount of a P2X7 receptor antagonist to the subject, showcasing her commitment to advancing HIV treatment options.
Career Highlights
Throughout her career, Inna has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université Paris Est Créteil Val de Marne. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Inna Menkova-Garnier has collaborated with notable colleagues, including Yves Levy and Jean-Daniel Lelievre. These partnerships have enriched her research and expanded the impact of her innovations in the medical community.
Conclusion
Inna Menkova-Garnier is a pioneering inventor whose work in HIV research has the potential to improve the lives of many individuals. Her dedication to innovation and collaboration highlights the importance of continued research in the fight against HIV.